Amilo-5MER (5-MP) TFA is an orally active and selective Serum Amyloid A (SAA) inhibitor. Amilo-5MER TFA specifically inhibits the release of pro-inflammatory cytokines IL-6 and IL-1beta from SAA-activated cells. Amilo-5MER TFA reduces chronic inflammation and relieves symptoms of diseases such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and multiple sclerosis (MS). Amilo-5MER TFA is promising for research of autoimmune diseases and chronic inflammatory diseases[1].
Molecular Weight:
576.66 (free base)
Purity:
99.63
Formula:
C23H40N6O9S.xC2HF3O2
Target:
Amyloid-beta,Interleukin Related
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted